Connor, Clark & Lunn Investment Management Ltd. Aquestive Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.31 - $4.5 $396,354 - $772,119	-171,582 Reduced 78.21%	47,817 $124,000
Q1 2024 May 09, 2024	SELL	$2.01 - $6.09 $84,807 - $256,955	-42,193 Reduced 16.13%	219,399 $934,000
Q4 2023 Feb 09, 2024	BUY	$1.29 - $2.47 $17,755 - $33,997	13,764 Added 5.55%	261,592 $528,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.24 $46,347 - $69,211	30,898 Added 14.24%	247,828 $379,000
Q2 2023 Aug 10, 2023	BUY	$1.06 - $2.49 $229,945 - $540,155	216,930 New	216,930 $357,000
Q2 2022 Aug 05, 2022	SELL	$0.64 - $2.57 $20,093 - $80,687	-31,396 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.28 - $4.26 $6,871 - $12,839	3,014 Added 10.62%	31,396 $82,000
Q4 2021 Feb 10, 2022	BUY	$3.69 - $6.37 $104,729 - $180,793	28,382 New	28,382 $110,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

Bratton Capital Management, L.P. Fort Worth, TX

9.81M
Shares

$45 Million
100.0% of portfolio
Vr Adviser, LLC New York, NY

5.56M
Shares

$25.5 Million
2.87% of portfolio
Black Rock Inc. New York, NY

5.45M
Shares

$25 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.26M
Shares

$19.6 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

2.77M
Shares

$12.7 Million
0.0% of portfolio

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account